Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Resolving turbidity is an analytical laboratory process focused on clearing the cloudiness or haziness of a liquid sample to facilitate accurate measurement, particularly in spectrophotometric and automated clinical assays. Turbidity is caused by the presence of suspended particles, such as lipids (lipemia), proteins, or microorganisms, which scatter light and interfere with the detection of light absorbance or fluorescence (StatPearls, 2023; https://www.ncbi.nlm.nih.gov/books/NBK549806/). Common methods to resolve turbidity include ultra-centrifugation, filtration, or the addition of chemical clearing agents like detergents or enzymes to degrade the interfering particles. This term refers to a methodology in sample preparation and diagnostic medicine rather than a biological molecule, receptor, or enzymatic pathway. Because it is a physical or chemical procedure performed ex vivo on a specimen, it is not considered a therapeutic target. Therefore, it lacks specific biological functions, disease-modifying roles, or interactions with therapeutic drug classes.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Resolving turbidity.